author-photo

Evelyn Loyer

University of Texas MD Anderson Cancer Center

5

Papers

168

Citations

Citation Trend

Filter By

Papers (4) Sort By

Journal Conference Others

Use of bevacizumab to reduce the rate of oxaliplatin-induced thrombocytopenia and splenomegaly.

2012 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (1)
Effect of bevacizumab on rate of oxaliplatin-induced thrombocytopenia and splenomegaly.

2012 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (1)
Oxaliplatin-Mediated Increase in Spleen Size As a Biomarker for the Development of Hepatic Sinusoidal Injury

2010 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (153)
Phase II Study of Oxaliplatin in Patients with Relapsed or Refractory Non-Hodgkin’s Lymphoma: Final Results.

2004 Blood
Show All
- Source
- Cite
- Save
Citations (0)